Breast cancer

Giving breast cancer patients radiotherapy and chemotherapy at the same time significantly cuts the risk their tumors will come back and should be considered as a new treatment approach across the world, cancer experts said on Sunday. The double treatment, known as synchronous chemoradiation, could also save lives among people with breast cancer, a disease that currently kills 425,000 women a year worldwide, according to the British experts who conducted a major scientific study. They said the synchronous treatment, which the study showed has limited side effects and does not harm patients' quality of life, should be considered for use by all breast cancer doctors.

Breast cancer research

An Indian oncologist is among three experts in the U.K. who have achieved a breakthrough in the treatment of breast cancer after a 10-year trial that demonstrates that a single dose of radiation during surgery is just as effective as a prolonged course of radiotherapy.

Goa-origin Jayant Vaidya, who works at the University College, Royal Free and Whittington Hospitals, designed and led the trial called interoperative radiotherapy (TARGIT) involving 2,000 women along with oncologists Jeffrey Tobias and Mike Baum. The new approach means selected patients receive just one dose of radiation during surgery to remove breast cancer. A probe is inserted into the breast so that it can target the exact site of the cancer.

Dr. Vaidya said: “This has been my dream for the last 15 years. The new treatment could mean that many more women could conserve their breasts. TARGIT saves time, money and breasts.” He added: “Scientifically, the results change the way of thinking about breast cancer and its treatment.